Intravenous glucose intake independently related to intensive care unit and hospital mortality: an argument for glucose toxicity in critically ill patients

Objective It is assumed that the toxic effects of glucose play a role in the outcome of critically ill patients. We studied the impact of the amount of infused glucose as a determinant of mortality.

[1]  A. Malhotra,et al.  Stress-induced hyperglycemia. , 2001, Critical care clinics.

[2]  T. Evans,et al.  Glucose control and mortality in critically ill patients. , 2004, JAMA.

[3]  James Stephen Krinsley,et al.  Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. , 2003, Mayo Clinic proceedings.

[4]  C. Wolf‐peeters,et al.  Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients , 2005, The Lancet.

[5]  G. Van den Berghe.  How does blood glucose control with insulin save lives in intensive care? , 2004, The Journal of clinical investigation.

[6]  Miet Schetz,et al.  Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control* , 2003, Critical care medicine.

[7]  B A Mizock,et al.  Alterations in fuel metabolism in critical illness: hyperglycaemia. , 2001, Best practice & research. Clinical endocrinology & metabolism.

[8]  R. Sheridan,et al.  Maximal parenteral glucose oxidation in hypermetabolic young children: a stable isotope study. , 1998, JPEN - Journal of Parenteral and Enteral Nutrition.

[9]  L. Tappy,et al.  Autoregulation of glucose production in health and disease. , 1999, Current opinion in clinical nutrition and metabolic care.

[10]  R. Marfella,et al.  Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress , 2002, Circulation.

[11]  AntonioCeriello,et al.  Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans , 2002 .

[12]  R. Andrassy,et al.  Short-term hyperglycemia depresses immunity through nonenzymatic glycosylation of circulating immunoglobulin. , 1989, The Journal of trauma.

[13]  A. Kitabchi,et al.  Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. , 2002, The Journal of clinical endocrinology and metabolism.

[14]  C. Apstein.  Increased glycolytic substrate protection improves ischemic cardiac dysfunction and reduces injury. , 2000, American heart journal.

[15]  Ning Li,et al.  Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations. , 2003, World journal of gastroenterology.

[16]  L. Khaodhiar,et al.  Perioperative hyperglycemia, infection or risk? , 1999, Current opinion in clinical nutrition and metabolic care.

[17]  Dieter Mesotten,et al.  Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. , 2004, The Journal of clinical endocrinology and metabolism.

[18]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.